Ammar Ahmed
Southfield, MINPI 1962064196
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,478 of the $6,002 with a category attached, or 74.6%. 21 manufacturers reported payments, led by Abbott at 40.9% of the total. 2025 is the largest year on record at $3,688, more than ten times the $16 reported in 2021.
Across 95 payments — averaging $63.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Amgen$730
- Inari Medical, Inc.$641
- Chiesi USA, Inc.$426
- Boston Scientific$243
- Sanofi$233
- plus $1K from 15 others
What the payments were for
- Travel & lodging$1,44824%
- Food & beverage$4,47875%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 23 | $2,453 |
| Amgen | 6 | $730 |
| Inari Medical, Inc. | 12 | $641 |
| Chiesi USA, Inc. | 16 | $426 |
| Boston Scientific | 4 | $243 |
| Sanofi | 2 | $233 |
| Boehringer Ingelheim | 3 | $233 |
| Abiomed | 6 | $168 |
| Kestra Medical Technology Services, Inc. | 2 | $153 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Philips North America LLC | 1 | $111 |
| Edwards Lifesciences | 4 | $103 |
| Pfizer | 4 | $95 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $76 |
| Medtronic | 1 | $54 |
| Stryker | 2 | $41 |
| AstraZeneca | 2 | $30 |
| Getinge USA Sales, LLC | 1 | $24 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Lantheus Medical Imaging, Inc. | 1 | $23 |
| CSL Behring | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$1,540
- Repatha$730
- FLOWTRIEVER CATHETER, S$465
- CT THROMBECTOMY SYSTEM KIT$465
- FABRAZYME$150
- CARDIOMEMS$148
- AVVIGO Guidance System$146
- ENSITE$144
- CAMZYOS$125
- Assure WCD$125
- JARDIANCE$115
- (5027) Intact Vascular Undivided$111
- KENGREAL$102
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 42 | $449 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.